from Reuters: Health News https://ift.tt/2ViZvoS
Friday, 21 February 2020
FDA approves Eli Lilly's Trulicity to reduce cardiovascular risks in type 2 diabetic patients
Eli Lilly and Co said on Friday the U.S. Food and Drug Administration has approved Trulicity for reducing cardiovascular risk factors in type 2 diabetic patients.
from Reuters: Health News https://ift.tt/2ViZvoS
from Reuters: Health News https://ift.tt/2ViZvoS
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment